In Vivo Biofilm Accumulation on Implants With 3 Different Surfaces

Sponsor
Malmö University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06049121
Collaborator
(none)
10
14

Study Details

Study Description

Brief Summary

A frequent sequela of peri-implantitis itself, but also of its surgery, is the exposure of the implant surface to the oral environment. This moderately-rough surface with threads, when exposed to the oral environment, is difficult to clean. Therefore, in cases where the implant surface is expected to remain exposed or to be in direct contact with the peri-implant mucosa, implantoplasty has been proposed to obtain a smoother surface. A smoother surface should allow more efficient plaque control. This in vivo study aims to evaluate potential differences in terms of plaque accumulation between 3 different implant surfaces.

Ten participants will wear the removable splint carrying 2 implants of each type of surface (i.e., turned, modified, and modified treated with implantoplasty) for 3 days and they will be asked to remove it to perform their (usual) oral hygiene and immerse the device in cold-tap water. On day 3, the removable splint will be collected for analysis. The area of biofilm covering the implants will be quantified with different methods.

Condition or Disease Intervention/Treatment Phase
  • Other: moderately rough surface
  • Other: implantoplasty

Detailed Description

The aim of this in vivo study is to evaluate potential differences in terms of plaque accumulation among 3 different implant surfaces (i.e., turned, modified, and modified treated with implantoplasty) in a larger population.

Test and control implants have the same initial dimensions, with threads evenly distributed through the entire cylindrical body.

Splint fabrication At the first visit, a maxillary alginate impression and a gypsum cast will be produced for every participant. This cast will be used to build a removable vacuum splint, which in turn will allow to carry six implants during the study period (i.e., 2 implants of each group T, M, I). Both on the right- and left-buccal aspects of the cast, three implants (i.e., 1 implant of each group T, M, I) will be randomly allocated and secured in their position prior to making the vacuum splint. The splint will be individually trimmed and polished to provide both retention and comfort.

At the second visit, splints will be tried and, if necessary, adjusted to avoid any discomfort. Participants will be instructed in detail on how to wear and handle the splint.

At the third visit, splints will be collected and stored for analyses.

Sample size calculation The only previous study with a similar study design (Azzola et al., 2020) included only a single participant. Based on the presented data of this specific study and due to the large difference between the test and control group, a reasonable sample size calculation was not feasible. Thus, a sample size of 10 participants was arbitrarily chosen for the present study.

Ethical Considerations All splints will be individually adapted, and implants will be fixated on the buccal aspect to avoid any interference while speaking. Also, mucosal and gingival irritation will be avoided by polishing the splints on the edges and keeping a distance from the gingival margin. Further, as participants will be instructed to remove the splint to brush and floss their teeth on a regular basis, there will be no increased risk of caries or gingivitis due to biofilm accumulation during the 3-day study period.

Study Design

Study Type:
Observational
Anticipated Enrollment :
10 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
In Vivo Biofilm Accumulation on Implants With 3 Different Surfaces
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
May 23, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Outcome Measures

Primary Outcome Measures

  1. quantification of the biofilm [3 days]

    Evaluated on a photograph, the area of dental biofilm accumulated

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • adults, > 18 years old

  • systemically healthy

  • full mouth healthy periodontal conditions

Exclusion Criteria

  • current pregnancy or breastfeeding

  • heavy smokers (> 10 cigarettes per day)

  • antibiotic intake in the previous 3 months

  • orthodontic appliances in the upper jaw

  • removable prosthesis in the upper jaw

  • extensive implant-supported restorations in the upper jaw

  • active carious lesions

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Malmö University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andreas Stavropoulos, Professor, Malmö University
ClinicalTrials.gov Identifier:
NCT06049121
Other Study ID Numbers:
  • 1
First Posted:
Sep 21, 2023
Last Update Posted:
Sep 21, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andreas Stavropoulos, Professor, Malmö University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 21, 2023